Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1955 1
1966 1
1967 1
1969 1
1971 1
1974 1
1979 1
1980 1
1986 1
1988 1
1991 2
1992 4
1993 1
1994 1
1995 1
1996 4
1997 1
1998 2
2000 1
2001 1
2003 1
2005 1
2006 1
2007 3
2009 1
2010 3
2011 5
2012 7
2013 11
2014 7
2015 11
2016 9
2017 6
2018 12
2019 11
2020 3
2021 2
Text availability
Article attribute
Article type
Publication date

Search Results

110 results
Results by year
Filters applied: . Clear all
Page 1
mTORC1 and mTORC2 in cancer and the tumor microenvironment.
Kim LC, Cook RS, Chen J. Kim LC, et al. Among authors: cook rs. Oncogene. 2017 Apr 20;36(16):2191-2201. doi: 10.1038/onc.2016.363. Epub 2016 Oct 17. Oncogene. 2017. PMID: 27748764 Free PMC article. Review.
Biological Consequences of MHC-II Expression by Tumor Cells in Cancer.
Axelrod ML, Cook RS, Johnson DB, Balko JM. Axelrod ML, et al. Among authors: cook rs. Clin Cancer Res. 2019 Apr 15;25(8):2392-2402. doi: 10.1158/1078-0432.CCR-18-3200. Epub 2018 Nov 21. Clin Cancer Res. 2019. PMID: 30463850 Free PMC article. Review.
RAS/MAPK Activation Is Associated with Reduced Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancer: Therapeutic Cooperation Between MEK and PD-1/PD-L1 Immune Checkpoint Inhibitors.
Loi S, Dushyanthen S, Beavis PA, Salgado R, Denkert C, Savas P, Combs S, Rimm DL, Giltnane JM, Estrada MV, Sánchez V, Sanders ME, Cook RS, Pilkinton MA, Mallal SA, Wang K, Miller VA, Stephens PJ, Yelensky R, Doimi FD, Gómez H, Ryzhov SV, Darcy PK, Arteaga CL, Balko JM. Loi S, et al. Among authors: cook rs. Clin Cancer Res. 2016 Mar 15;22(6):1499-509. doi: 10.1158/1078-0432.CCR-15-1125. Epub 2015 Oct 29. Clin Cancer Res. 2016. PMID: 26515496 Free PMC article.
Selective mTORC2 Inhibitor Therapeutically Blocks Breast Cancer Cell Growth and Survival.
Werfel TA, Wang S, Jackson MA, Kavanaugh TE, Joly MM, Lee LH, Hicks DJ, Sanchez V, Ericsson PG, Kilchrist KV, Dimobi SC, Sarett SM, Brantley-Sieders DM, Cook RS, Duvall CL. Werfel TA, et al. Among authors: cook rs. Cancer Res. 2018 Apr 1;78(7):1845-1858. doi: 10.1158/0008-5472.CAN-17-2388. Epub 2018 Jan 22. Cancer Res. 2018. PMID: 29358172 Free PMC article.
MEK activation modulates glycolysis and supports suppressive myeloid cells in TNBC.
Franklin DA, Sharick JT, Ericsson-Gonzalez PI, Sanchez V, Dean PT, Opalenik SR, Cairo S, Judde JG, Lewis MT, Chang JC, Sanders ME, Cook RS, Skala MC, Bordeaux J, Orozco Bender J, Vaupel C, Geiss G, Hinerfeld D, Balko JM. Franklin DA, et al. Among authors: cook rs. JCI Insight. 2020 Aug 6;5(15):e134290. doi: 10.1172/jci.insight.134290. JCI Insight. 2020. PMID: 32634121 Free PMC article.
Molecular profiling of the residual disease of triple-negative breast cancers after neoadjuvant chemotherapy identifies actionable therapeutic targets.
Balko JM, Giltnane JM, Wang K, Schwarz LJ, Young CD, Cook RS, Owens P, Sanders ME, Kuba MG, Sánchez V, Kurupi R, Moore PD, Pinto JA, Doimi FD, Gómez H, Horiuchi D, Goga A, Lehmann BD, Bauer JA, Pietenpol JA, Ross JS, Palmer GA, Yelensky R, Cronin M, Miller VA, Stephens PJ, Arteaga CL. Balko JM, et al. Among authors: cook rs. Cancer Discov. 2014 Feb;4(2):232-45. doi: 10.1158/2159-8290.CD-13-0286. Epub 2013 Dec 19. Cancer Discov. 2014. PMID: 24356096 Free PMC article.
Efferocytosis in the tumor microenvironment.
Werfel TA, Cook RS. Werfel TA, et al. Among authors: cook rs. Semin Immunopathol. 2018 Nov;40(6):545-554. doi: 10.1007/s00281-018-0698-5. Epub 2018 Sep 5. Semin Immunopathol. 2018. PMID: 30187085 Free PMC article. Review.
110 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page